Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shaw T Chen"'
Autor:
Jieqiang Zhu, Xiaohui Fan, Yiyu Cheng, Rajiv Agarwal, Christine M V Moore, Shaw T Chen, Weida Tong
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87462 (2014)
The overall control of the quality of botanical drugs starts from the botanical raw material, continues through preparation of the botanical drug substance and culminates with the botanical drug product. Chromatographic and spectroscopic fingerprinti
Externí odkaz:
https://doaj.org/article/1addb613c5744118a5ae49e6ded43797
Publikováno v:
Nature Biotechnology. 26:1077-1083
Although new botanical drugs pose many challenges for both industry and the FDA, approval of the first botanical prescription drug shows they can be successfully met.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a15c4a28e802b2f17e1ac29fb742d4
https://doi.org/10.1038/nbt1008-1077
https://doi.org/10.1038/nbt1008-1077
Autor:
Shaw T. Chen
Publikováno v:
Kampo Medicine. 56:231-241
人間の病気の治療薬として昔から多くの生薬がさまざまな地域で処方されているが, 現代医学の基準に適合した厳しい臨床試験を受けたものはほとんどない。新規の生薬製剤の臨床開発
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5322261bc34331daf049ae55d404cc3d
https://doi.org/10.3937/kampomed.56.231
https://doi.org/10.3937/kampomed.56.231
Autor:
Shaw T. Chen
Publikováno v:
Fitoterapia. 82:14-16
Investigators and sponsors of dietary supplement research need to know the relevant regulatory requirements and how to comply with them. This brief review describes how research on dietary supplements is regulated by FDA. In general, whether an FDA s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e3d1ba7c13f4a9660b7b89fef8be5ac
https://doi.org/10.1016/j.fitote.2010.11.011
https://doi.org/10.1016/j.fitote.2010.11.011
Autor:
Shaw T. Chen, Weida Tong, Jieqiang Zhu, Christine M. V. Moore, Rajiv Agarwal, Xiaohui Fan, Yiyu Cheng
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e87462 (2014)
PLoS ONE, Vol 9, Iss 1, p e87462 (2014)
The overall control of the quality of botanical drugs starts from the botanical raw material, continues through preparation of the botanical drug substance and culminates with the botanical drug product. Chromatographic and spectroscopic fingerprinti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f3eafecee889bbf73c719699e75d841
http://europepmc.org/articles/PMC3909187
http://europepmc.org/articles/PMC3909187
Autor:
Shaw T. Chen
Publikováno v:
Drug Information Journal. 29:27-32
Aside from technical problems which may impede the reviewing process, approval of a new drug depends on whether the clinical data support the claims of efficacy and safety. Using several recent new drug applications (NDAs) of cardiorenal drugs as exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::522e5a43725cbde7877a5cdfda66fa41
https://doi.org/10.1177/009286159502900104
https://doi.org/10.1177/009286159502900104
Autor:
Stephen D. Hall, Peter K. Honig, Michael D. Murray, Freddie Ann Hoffman, Paul B. Watkins, Cosette Serabjit-Singh, Shaw T. Chen, Shiew-Mei Huang, Jonca Bull, Paul M. Coates, Joseph M. Betz, Lori A. Love, Gregory L. Kearns
Publikováno v:
Clinical pharmacology and therapeutics. 75(1)
Shiew-Mei Huang, PhD, Stephen D. Hall, PhD, Paul Watkins, MD, Lori A. Love, MD, PhD, Cosette Serabjit-Singh, PhD, Joseph M. Betz, PhD, Freddie Ann Hoffman, MD, Peter Honig, MD, Paul M. Coates, PhD, Jonca Bull, MD, Shaw T. Chen, MD, PhD, Gregory L. Ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d591e7e049a76ad3be4dbf60d323d1df
https://pubmed.ncbi.nlm.nih.gov/15900292
https://pubmed.ncbi.nlm.nih.gov/15900292